Status:
COMPLETED
Thumb vs Great Toe Recovery
Lead Sponsor:
Mayo Clinic
Conditions:
Residual Neuromuscular Blockade
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researches are comparing the accuracy of measuring muscle relaxation in the thumb versus the great toe.
Eligibility Criteria
Inclusion
- Age \> or = 18 years old
- Patients willing to participate and provide an informed consent
- Patients undergoing an elective surgical procedure that requires use of non-depolarizing NMBA agents administered intraoperatively.
- Patients with planned administration of sugammadex as a neuromuscular blocking reversal agent.
Exclusion
- Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
- Patients with systemic neuromuscular diseases such as myasthenia gravis
- Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.
- Patients having surgery that would involve prepping the arm or leg into the sterile field
Key Trial Info
Start Date :
August 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2021
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT04312256
Start Date
August 18 2020
End Date
January 19 2021
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224